Published in Immunotherapy Weekly, August 29th, 2007
"Novel small molecules and biological agents currently in clinical development may help to minimize the use of calcineurin inhibitors...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.